Home/Filings/4/0001140361-17-037024
4//SEC Filing

Resnick Joshua 4

Accession 0001140361-17-037024

CIK 0001348911other

Filed

Sep 28, 8:00 PM ET

Accepted

Sep 29, 8:17 PM ET

Size

6.2 KB

Accession

0001140361-17-037024

Insider Transaction Report

Form 4
Period: 2017-09-27
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2017-09-27+6,0006,000 total
    Exercise: $6.71Exp: 2027-09-26Common Stock (6,000 underlying)
Footnotes (2)
  • [F1]The option vests over a 12 month period: 1/12th on October 27, 2017, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date.
  • [F2]The option is held by the reporting person for the benefit of SV Health Investors, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Documents

1 file

Issuer

KalVista Pharmaceuticals, Inc.

CIK 0001348911

Entity typeother

Related Parties

1
  • filerCIK 0001690959

Filing Metadata

Form type
4
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 8:17 PM ET
Size
6.2 KB